Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Medication 1 improved hair quality and growth more effectively than medication 2 and the placebo.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Nutrafol® Women's Capsules safely and effectively promote hair growth in women with thinning hair.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Hyperbaric oxygen therapy improves hair growth and quality of life in androgenic alopecia patients.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Baricitinib was effective in treating both early and late onset alopecia areata.

The supplement helps improve hair growth and reduce hair shedding.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

AA-PRP injections effectively increase hair count and thickness for male pattern hair loss.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

The hair growth solution reduced hair loss and increased hair thickness in a small group of patients.

PRP treatment increased hair density, especially in men and younger patients with AGA.

Low-dose dutasteride effectively and safely promotes hair growth in men.